Corbus Pharmaceuticals
CRBP
CRBP
34 hedge funds and large institutions have $4.54M invested in Corbus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $5.01M → $4.54M (-$466K)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
34
Holding in Top 10
–
Calls
$214K
Puts
$1K
Top Buyers
| 1 | +$126K | |
| 2 | +$7.19K | |
| 3 | +$5.82K | |
| 4 |
Morgan Stanley
New York
|
+$4.98K |
| 5 |
Citigroup
New York
|
+$3.42K |
Top Sellers
| 1 | -$75.7K | |
| 2 | -$7.03K | |
| 3 | -$5.2K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$3.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.39K |